KALARIS THERAPEUTICS, INC. Income Taxes Paid
KALARIS THERAPEUTICS, INC. (KLRS) reported Income Taxes Paid of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-17.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-03-17
- KALARIS THERAPEUTICS, INC. income taxes paid, net for the quarter ending 2023-12-31 was -$131.00K.
- KALARIS THERAPEUTICS, INC. income taxes paid, net for the quarter ending 2023-09-30 was $1.00K.
- KALARIS THERAPEUTICS, INC. income taxes paid, net for the quarter ending 2022-12-31 was -$390.00K.
- KALARIS THERAPEUTICS, INC. income taxes paid, net for the quarter ending 2022-09-30 was $0.00.
- KALARIS THERAPEUTICS, INC. income taxes paid, net for fiscal 2025 was $0.00.
- KALARIS THERAPEUTICS, INC. income taxes paid, net for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- KALARIS THERAPEUTICS, INC. income taxes paid, net for fiscal 2023 was $220.00K, a 64.11% decline from fiscal 2022.
- KALARIS THERAPEUTICS, INC. income taxes paid, net for fiscal 2022 was $613.00K.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-17 | |||
| 2024-12-31 | $0.00 10-K · filed 2026-03-17 | |||
| 2023-12-31 | -$131.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | -$130.00K derived: sum of 2 quarters · filed 2025-03-07 | $220.00K 10-K · filed 2025-03-07 | |
| 2023-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $351.00K 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | $350.00K 10-Q · filed 2024-08-09 | |||
| 2022-12-31 | -$390.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$390.00K derived: sum of 2 quarters · filed 2024-03-15 | $113.00K derived: sum of 3 quarters · filed 2024-03-15 | $613.00K 10-K · filed 2024-03-15 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $503.00K derived: sum of 2 quarters · filed 2023-11-02 | $1.00M 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $503.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $1.00M 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | $500.00K 10-Q · filed 2023-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |